These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34142388)

  • 21. Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity.
    Kirkorian AY; Weitz NA; Tlougan B; Morel KD
    Pediatr Dermatol; 2014; 31(1):33-7. PubMed ID: 24224977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa.
    Ebens CL
    EMBO Mol Med; 2021 Oct; 13(10):e14864. PubMed ID: 34515407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5
    Niebergall-Roth E; Dieter K; Daniele C; Fluhr S; Khokhrina M; Silva I; Ganss C; Frank MH; Kluth MA
    Cells; 2023 May; 12(11):. PubMed ID: 37296590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
    Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
    Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.
    Krämer S; Lucas J; Gamboa F; Peñarrocha Diago M; Peñarrocha Oltra D; Guzmán-Letelier M; Paul S; Molina G; Sepúlveda L; Araya I; Soto R; Arriagada C; Lucky AW; Mellerio JE; Cornwall R; Alsayer F; Schilke R; Antal MA; Castrillón F; Paredes C; Serrano MC; Clark V
    Spec Care Dentist; 2020 Nov; 40 Suppl 1(Suppl 1):3-81. PubMed ID: 33202040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
    Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
    Fuentes I; Yubero MJ; Morandé P; Varela C; Oróstica K; Acevedo F; Rebolledo-Jaramillo B; Arancibia E; Porte L; Palisson F
    Int Wound J; 2023 Mar; 20(3):774-783. PubMed ID: 36787273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recessive dystrophic epidermolysis bullosa: presentation of two forms.
    Medenica L; Lens M
    Dermatol Online J; 2008 Mar; 14(3):2. PubMed ID: 18627704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future applications of 3D bioprinting: A promising technology for treating recessive dystrophic epidermolysis bullosa.
    Popp CM; Miller WC; Eide CR; Tolar J
    Exp Dermatol; 2022 Mar; 31(3):384-392. PubMed ID: 34699623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: rapidly healing epidermolysis bullosa wound after ablative fractional resurfacing.
    Krakowski AC; Ghasri P
    Pediatrics; 2015 Jan; 135(1):e207-10. PubMed ID: 25535263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recessive dystrophic epidermolysis bullosa results in painful small fibre neuropathy.
    von Bischhoffshausen S; Ivulic D; Alvarez P; Schuffeneger VC; Idiaquez J; Fuentes C; Morande P; Fuentes I; Palisson F; Bennett DLH; Calvo M
    Brain; 2017 May; 140(5):1238-1251. PubMed ID: 28369282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
    Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study.
    Reimer A; Hess M; Schwieger-Briel A; Kiritsi D; Schauer F; Schumann H; Bruckner-Tuderman L; Has C
    Br J Dermatol; 2020 Jun; 182(6):1437-1448. PubMed ID: 31487386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
    Bornert O; Hogervorst M; Nauroy P; Bischof J; Swildens J; Athanasiou I; Tufa SF; Keene DR; Kiritsi D; Hainzl S; Murauer EM; Marinkovich MP; Platenburg G; Hausser I; Wally V; Ritsema T; Koller U; Haisma EM; Nyström A
    J Invest Dermatol; 2021 Apr; 141(4):883-893.e6. PubMed ID: 32946877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral microbiome in children with dystrophic recessive epidermolysis bullosa].
    Korolenkova MV; Poberezhnaya AA; Dmitrieva NA
    Stomatologiia (Mosk); 2022; 101(1):46-52. PubMed ID: 35184533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.
    Ebens CL; McGrath JA; Tamai K; Hovnanian A; Wagner JE; Riddle MJ; Keene DR; DeFor TE; Tryon R; Chen M; Woodley DT; Hook K; Tolar J
    Br J Dermatol; 2019 Dec; 181(6):1238-1246. PubMed ID: 30843184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa.
    Nyström A; Bornert O; Kühl T; Gretzmeier C; Thriene K; Dengjel J; Pfister-Wartha A; Kiritsi D; Bruckner-Tuderman L
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E705-E714. PubMed ID: 29305555
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.